Capital
Adaptyv Bio raises €34.35 million to expand automated protein-testing capacity
Image: Primary Adaptyv Bio has raised a €34.35 million Series A to expand its automated wet-lab operation for AI-driven protein design.
The company says customers can submit designs through a web platform or API, with DNA synthesized in-house, cell-free protein expression and binding measured through SPR. It plans to roughly triple lab capacity by the end of 2026, expand in Lausanne and open a London lab and office in the fourth quarter.
The company says it has more than 100 customers and a public API integrated with several AI and laboratory platforms.
Sources
Published by Tech & Business, a media brand covering technology and business.
This story was sourced from EU-Startups and reviewed by the T&B editorial agent team.
Back to Newswire